Study on Gynecological Rare Cancers

National Cancer Institute, Naples500 enrolled

Overview

This is a prospective, observational, multicenter study on gynecological rare tumors.

This is a prospective registry aimed to better understand prognosis, clinical and pathological features, management of this rare cancer conditions for improving standard of care.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Gynecologic Cancer

Interventions

chemotherapy, surgeryOTHER

this is an observational prospective study, therefore no intervention is planned. Patients perform medical and surgical treatment as per standard of case.

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * rare gynecological malignancies * written informed consent * patient fit for follow-up Exclusion criteria -written informed consent not provided

Locations (2)

Ginecologia e Ostetricia, IRCCS Ospedale San Raffaele

Milan, Italy

RECRUITING

IRCCS Fondazione G Pascale

Naples, Italy

RECRUITING

Outcomes

Primary Outcomes

Prevalence of gynecologic rare malignancies

To describe the prevalence of gynecologic rare tumors

Time frame: 5 years

Central Contacts

Francesco Perrone, MD

CONTACT

0039 081 1777 0276 f.perrone@istitutotumori.na.it

Giorgia Mangili, MD

CONTACT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.